Articles

  • Solid-State Strategy as a Development Discipline

    October 20, 2026
    For decades, solid-state chemistry has been recognized as a critical determinant of pharmaceutical performance and quality, yet solid-state decisions continue to be routinely deferred in early ... read more

  • From Molecule to Patient Impact

    October 13, 2026
    Closing the non-adherence gap will require closer collaboration across the healthcare ecosystem, bringing together formulation scientists, excipient specialists, drug developers, regulators, ... read more

  • A Consistent Standard for Dust Safety

    September 29, 2026
    The adoption of the National Fire Protection Association’s unified standard for combustible dusts and particulate solids, NFPA 660, marks an important evolution in combustible dust safety. Rather than... read more

  • From Shore to Shore

    September 29, 2026
    More than six decades after Hovione’s humble basement beginnings, the company is still betting on the value of being global. But today, that means something different. It’s not simply about having ... read more

  • Can OSD Handle the GLP-1 Appetite?

    September 25, 2026
    The injectable weight-loss drug boom didn’t just strain drugmakers with approved products, it reshaped the entire pharma ecosystem, forcing suppliers and manufacturers to reorganize around GLP-1s. read more

  • Oral Solid Dose Regulatory Approval Update

    August 17, 2026
    CDER has approved 46 novel drugs so far, more than half of which are oral solid dose formulations. Here’s a closer look at the 2026 OSD approvals. read more

  • Root Cause Analysis of Tablet Manufacturing Issues

    July 14, 2026
    Many formulation challenges such as poor flow, segregation, capping and weak tablets can be traced to suboptimal micromeritics properties. read more

  • Creating Amorphous Solid Dispersions via Spray Drying

    June 29, 2026
    Spray-dried ASDs are increasingly used to improve bioavailability for complex new molecules, making efficient process development tools and methodologies essential for accelerating commercialization. read more

  • When AI Isn't Enough

    June 26, 2026
    While AI offers significant advantages in data processing and analytical capability, its use in regulated industries must be carefully governed. Organizations must balance innovation with compliance ... read more

  • Accelerating Value with Data

    June 09, 2026
    Big data and advanced technology have reshaped most industries, and oral solid dose is no exception. read more

  • Driving the Data-Rich Future of OSDs

    June 02, 2026
    Data-rich, data-led, data-driven — these terms increasingly define modern oral solid dose development. In this roundtable, industry leaders discuss what it will take to navigate this next phase of OSD... read more

  • Peptide-to-Small-Molecule Translation

    April 13, 2026
    Recent advances are turning what was once a trial-and-error exercise into a disciplined and reproducible design workflow. read more

  • Particle Size Meets Chemistry

    April 07, 2026
    As material complexity and regulatory expectations grow, LD-PCRS correlative characterization will support robust formulation design, process control, and risk-based decision-making. read more

  • Handling Machinability Challenges with Hard Shell Capsules

    March 31, 2026
    Machinability issues linked to capsule-related factors can disrupt production, increase waste and jeopardize delivery timelines. read more

  • The Hidden Complexity of Capsule Development

    March 24, 2026
    As small molecule pipelines continue to shift toward more complex, potent and sensitive APIs and as clinical trials similarly evolve toward greater complexity, the linear model of development is no ... read more
  • <<
  • >>